Omega Healthcare Investors (NYSE:OHI) had its price target lifted by Truist from $32.00 to $34.00 in a research report sent to investors on Monday, The Fly reports.
Several other equities analysts also recently issued reports on the company. Smith Barney Citigroup initiated coverage on Omega Healthcare Investors in a research report on Monday, July 13th. They set a neutral rating for the company. Raymond James lowered Omega Healthcare Investors from a strong-buy rating to an outperform rating and set a $34.00 target price on the stock. in a report on Monday, August 3rd. Zacks Investment Research lowered Omega Healthcare Investors from a buy rating to a hold rating in a report on Wednesday, September 9th. JMP Securities began coverage on Omega Healthcare Investors in a report on Monday, June 8th. They set a market perform rating on the stock. Finally, lifted their price target on Omega Healthcare Investors to $26.54 and gave the stock a sell rating in a research note on Tuesday, June 9th. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of Hold and an average target price of $33.63.
NYSE:OHI opened at $32.70 on Monday. The business’s 50-day moving average is $31.89 and its two-hundred day moving average is $30.38. The company has a debt-to-equity ratio of 1.25, a current ratio of 3.35 and a quick ratio of 3.35. Omega Healthcare Investors has a 12 month low of $13.33 and a 12 month high of $45.22. The firm has a market capitalization of $7.42 billion, a PE ratio of 19.01, a price-to-earnings-growth ratio of 4.15 and a beta of 0.85.
Omega Healthcare Investors (NYSE:OHI) last announced its earnings results on Wednesday, August 5th. The real estate investment trust reported $0.43 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.75 by ($0.32). Omega Healthcare Investors had a return on equity of 9.22% and a net margin of 39.17%. Equities analysts anticipate that Omega Healthcare Investors will post 3.06 EPS for the current year.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Pathstone Family Office LLC purchased a new position in Omega Healthcare Investors in the first quarter worth $49,000. Beese Fulmer Investment Management Inc. bought a new stake in Omega Healthcare Investors during the second quarter valued at approximately $49,000. Fifth Third Bancorp lifted its position in Omega Healthcare Investors by 84.1% during the first quarter. Fifth Third Bancorp now owns 1,948 shares of the real estate investment trust’s stock valued at $52,000 after purchasing an additional 890 shares during the last quarter. Parallel Advisors LLC lifted its position in Omega Healthcare Investors by 28.4% during the second quarter. Parallel Advisors LLC now owns 1,819 shares of the real estate investment trust’s stock valued at $54,000 after purchasing an additional 402 shares during the last quarter. Finally, Valeo Financial Advisors LLC lifted its position in Omega Healthcare Investors by 134.0% during the second quarter. Valeo Financial Advisors LLC now owns 1,872 shares of the real estate investment trust’s stock valued at $56,000 after purchasing an additional 1,072 shares during the last quarter. 71.63% of the stock is currently owned by hedge funds and other institutional investors.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Featured Story: What is a Fibonacci Channel?
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.